Parabolic Drugs (Delisted) share news and announcements
BSE: 533211Pharmaceuticals & Biotechnology
Last traded ₹5.50 on 25 Jan 2021
Delisted on 11 Aug 2021.
Parabolic Drugs share news and announcements
677 announcements, routine notices left out, newest first. Page 2 of 14.
Jul 2020
9 Jul · Shareholding for the Period Ended June 30, 2020
Shareholding Pattern for the Period Ended June 30, 2020. For more details, kindly Click ....9 Jul · Statement Of Investor Complaints For The Quarter Ended June 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Jun 2020
20 Jun · Shareholding for the Period Ended December 31, 2019
Shareholding Pattern for the Period Ended December 31, 2019. For more details, kindly Click ....20 Jun · Shareholding for the Period Ended September 30, 2019
Shareholding Pattern for the Period Ended September 30, 2019. For more details, kindly Click ....19 Jun · Compliance Certificate Under Regulation 7(3) Of SEBI (Listing Obligations & Disclosure Requirements) Regulation, 2015 For The Half Year Ended March 31, 2020
16 Jun · Certificate Under Regulation 40(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended March 31, 2020
12 Jun · Shareholding for the Period Ended March 31, 2020
Shareholding Pattern for the Period Ended March 31, 2020. For more details, kindly Click ....12 Jun · Statement Of Investor Complaints For The Quarter Ended March 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Aug 2019
Jul 2019
19 Jul · Shareholding for the Period Ended June 30, 2019
Shareholding Pattern for the Period Ended June 30, 2019. For more details, kindly Click ....15 Jul · Statement Of Investor Complaints For The Quarter Ended June 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Jun 2019
4 Jun · Legal
Exchange has sought clarification from Parabolic Drugs Limited with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Standalone audited report not submitted. -2. No Segment Reporting. -3. The company has not submitted the Statement of Modified Opinion or in case of unmodified opinion(s), a declaration to that effect to the Stock Exchange. -4. Financial results submitted is not as per format prescribed by SEBI The response of the Company is awaited.
May 2019
29 May · Corporate Insolvency Resolution Process
29 May · Corporate Insolvency Resolution Process
29 May · Corporate Insolvency Resolution Process
29 May · Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors
29 May · Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors
29 May · Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors
8 May · Compliance For Quarter Ending 31-03-2019
8 May · Compliance Certificate For Period Ended 31-03-2019
6 May · Shareholding for the Period Ended March 31, 2019
Shareholding Pattern for the Period Ended March 31, 2019. For more details, kindly Click ....6 May · Statement Of Investor Complaints For The Quarter Ended March 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Apr 2019
10 Apr · Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors
10 Apr · Corporate Insolvency Resolution Process
8 Apr · Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors
8 Apr · Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors
8 Apr · Corporate Insolvency Resolution Process
8 Apr · Corporate Insolvency Resolution Process
Mar 2019
7 Mar · Corporate Insolvency Resolution Process
6 Mar · Corporate Insolvency Resolution Process (CIRP)-Intimation of meeting of Committee of Creditors
Feb 2019
19 Feb · Legal
Exchange has sought clarification from Parabolic Drugs Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Board meeting notice not submitted. The response of the Company is awaited.
Jan 2019
29 Jan · Corporate Insolvency Resolution Process
29 Jan · Corporate Insolvency Resolution Process (CIRP)-Outcome of meeting of Committee of Creditors
18 Jan · Shareholding for the Period Ended December 31, 2018
Shareholding Pattern for the Period Ended December 31, 2018. For more details, kindly Click ....18 Jan · Statement Of Investor Complaints For The Quarter Ended December 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 014 Jan · Corporate Insolvency Resolution Process
12 Jan · Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)